共 23 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 82876-841-20 | Soothe Chewable | CHEWABLE GEL | 2023-08-01 | M001 |
| 2 | 82876-840-20 | Soothe Chewable | CHEWABLE GEL | 2023-08-01 | M001 |
| 3 | 82876-842-20 | Soothe Chewable | CHEWABLE GEL | 2023-08-01 | M001 |
| 4 | 82876-843-20 | Soothe Chewable | CHEWABLE GEL | 2023-08-01 | M001 |
| 5 | 82876-831-20 | Uplift Chewable | CHEWABLE GEL | 2023-08-01 | M011 |
| 6 | 82876-830-20 | Uplift Chewable | CHEWABLE GEL | 2023-08-01 | M011 |
| 7 | 82876-832-20 | Uplift Chewable | CHEWABLE GEL | 2023-08-01 | M011 |
| 8 | 82876-833-20 | Uplift Chewable | CHEWABLE GEL | 2023-08-01 | M011 |
| 9 | 82876-224-02 | Healing Hand Cream | CREAM | 2025-08-01 | M016 |
| 10 | 82876-504-02 | Bath Bomb 2-pack (Rose) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 11 | 82876-501-02 | Bath Bomb 2-pack (Lemon) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 12 | 82876-502-02 | Bath Bomb 2-pack (Lavender) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 13 | 82876-503-02 | Bath Bomb 2-pack (Orange) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 14 | 82876-508-06 | Bath Bomb 6-pack (Lavender) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 15 | 82876-505-02 | Bath Bomb 2-pack (Peppermint) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 16 | 82876-506-02 | Bath Bomb 2-pack (Eucalyptus) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 17 | 82876-507-06 | Bath Bomb 6-pack (Lemon) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 18 | 82876-510-06 | Bath Bomb 6-pack (Rose) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 19 | 82876-509-06 | Bath Bomb 6-pack (Orange) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 20 | 82876-511-06 | Bath Bomb 6-pack (Peppermint) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 21 | 82876-512-06 | Bath Bomb 6-pack (Eucalyptus) | TABLET, SOLUBLE | 2025-08-06 | M016 |
| 22 | 82876-221-02 | Healing Hand Cream 2000mg | SALVE | 2023-08-01 | M017 |
| 23 | 82876-010-49 | Cannarelief 1000mg | SALVE | 2023-08-01 | M017 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系